HotSheets by Year

 

HotSheets 2005

  • Free Bone Health Education Teleconference
  • Green Tea Thwarts Prostate Cancer
  • New NCI-Sponsored Trial of GTI-2040
  • Us TOO Board of Directors and Officers
  • Read more..
  • Message From Tom Kirk
  • Medicare Payments for Cancer Drugs
  • Lupron® Settlement Notification Begins
  • Us TOO Publications
  • Local Salvage Therapies After Radiation
  • Read more..
  • The Origin of PCa Support Groups
  • Us TOO Publications
  • Radiation Seeds May Be Enough
  • NIH Studies to Be Publicly Accessible
  • New Options for Incontinence
  • Exercise May Help Cancer Patients Recover
  • Read more..
  • FDA Agrees to File NDA for Abbott’s Xinlay
  • Finasteride May Reduce Cancer Mortality
  • Prostate Cancer Vaccine Improves Survival
  • 2005 Us TOO Executive Committee
  • Celebrex Inhibits Prostate Cancer Growth
  • No Broad FDA Approval for Combidex
  • Read more..
  • MR Method Assesses Cancer Aggressiveness
  • Good Long-Term Results with Brachytherapy
  • Tessera Launches New Prostate Cancer Test
  • Us Too Publications
  • Newly Re-Designed Us TOO Website
  • PSA + DRE Best At Spotting Prostate Cancer
  • Read more..
  • Us TOO International Accepted As
    National Health Council Member
  • Visit the 2005 AACR Annual Meeting
    Webcast
  • Us TOO Publications
  • Scientific Peer Review of Prostate Cancer Research Proposals for the DOD
  • Bone Protective Compound Identified in Onions
  • Read more..
  • Prostate Cancer Linked to Mother’s Genes
  • Vitamin D May Help in Prostate Cancer
  • Longer Screening Intervals Delay Detection
  • Us Too Publications
  • Us TOO Exhibits at the 2005 AUA Meeting
  • Breast Cancer Drug Could Benefit Prostate
  • Read more..
  • National Conference on Prostate Cancer 2005 Proves Successful
  • Companion and Family Members Share
    Insights at National Conference
  • Run, Walk ‘n Roll for Prostate Cancer
  • Us TOO Survey on Advanced Prostate Cancer
  • Exercise Improves Sexual Function After Prostate Cancer Radiotherapy
  • Read more..
  • Prostate Cancer Awareness Month
  • Medicare CAP Delayed
  • FDA’s ODAC to Review NDA for Xinlay
  • Xinlay Expanded Access Program Announced
  • Baby Boomers Confront Prostate Cancer
  • PSA Changes Over Time Predict Risk
  • Read more..
  • Us TOO Founders’ Fund Donations Grow
  • FDA’s ODAC Panel Rejects Abbott’s Xinlay
  • Us TOO Teams Up with Health Talk®
  • Antioxidants May Prevent Prostate Cancer
  • Don’t Forget About Matching Donations
  • Survey Research Participants Needed
  • Read more..
  • Us TOO Seeks Board Member Applicants
  • Acting FDA Head Drops Other Duty
  • Us TOO Publications
  • Sex Drug Subsidies to Pay Hurricane Aid
  • Possible New Biomarker for Prostate Cancer
  • Lawmakers Push to Repeal Medicare Part D
  • Cytogen Presents New Quadramet Data
  • Read more..
  • Us TOO Receives Four-Star Fiscal Rating
  • Likely Origins of Prostate Cancer Discovered
  • Zyflamend’s Benefits in Prostate Cancer
  • Us TOO Publications
  • PROVENGE® Gets Fast-Track FDA Status
  • Music Therapy for Cancer
  • Songs in Celebration and Support
  • Read more..

CLICK HERE and opt-in to receive free educational emails from Us TOO.